Healthcare & Life Sciences
Algen Biotechnologies
United States
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Algen Biotechnologies uses CRISPR and machine learning to identify disease-driving RNA messages at single-cell resolution to discover therapeutics targeting cancer, inflammation, and other diseases with high unmet medical need.
Explore Algen Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.